Insulet falls after lowering 2026 revenue growth forecast - PODD News | RalliesInsulet falls after lowering 2026 revenue growth forecast
P
PODD• Insulet lowers 2026 revenue growth outlook
- Shares of medical device maker Insulet fell 12.2% to $146.4 in premarket trading.
- The company lowered its 2026 revenue growth forecast to 20% to 22%, compared with its prior view of 21% to 23%.
- Insulet reported second-quarter adjusted profit per share of $1.66, above analysts' estimates of $1.45, according to LSEG data.
- It posted second-quarter revenue of $801.7 million, above analysts' estimates of $787.2 million, according to LSEG data.
- As of the last close, the stock was down 41.3% year to date.
•
